Jiahong Dental Completes BSE Listing Guidance Acceptance

Source: Jiahong Dental's "Announcement on Completion of Guidance and Acceptance for Public Issuance of Shares and Listing on the Beijing Stock Exchange"

DentalGoodNews｜July 2, 2026, Shenzhen Jiahong Dental Co.,Ltd. (hereinafter referred to as "Jiahong Dental") received the "Shenzhen Securities Regulatory Bureau's Letter of Completion of Acceptance of Guoxin Securities Co., Ltd.'s Guidance Work" (Shenzhen Securities Bureau Office Letter {2026} No. 95) from the Shenzhen Securities Regulatory Bureau. The company has passed the guidance acceptance of the Shenzhen Securities Regulatory Bureau under the guidance of Guoxin Securities.

Jiahong Dental was established in 2001, primarily engaged in the research, development, production, and sales of fixed dentures, removable dentures, and orthodontic products. The company's main manufacturing bases are located in Shenzhen, Zhuhai, and other places. According to disclosed data, the company currently has over 1,800 employees.

In terms of financial conditions, Jiahong Dental's audited net profit attributable to shareholders of the listed company (calculated based on the lower of the amounts before and after deducting non-recurring gains and losses) for 2024 and 2025 were RMB 51.5045 million and RMB 45.1263 million, respectively. The weighted average return on equity (ROE) was 9.79% and 8.03%, respectively, meeting the financial conditions for listing on the Beijing Stock Exchange (BSE) as stipulated in the "Listing Rules."

According to previous reports by DENTALGOODNEWS (Leading Dental Industry Media, DGN), Jiahong Dental withdrew its ChiNext IPO application in December 2021 and was officially approved to be transferred to the National Equities Exchange and Quotations (NEEQ) Innovation Layer on May 19, 2025. The company submitted IPO guidance filing materials for listing on the BSE to the Shenzhen Securities Regulatory Bureau on January 10, 2025, with the guidance period starting from January 18, 2025.

Currently, Jiahong Dental's subsequent public issuance of shares and listing on the BSE still faces risks of failing to pass the BSE's issuance and listing review or the China Securities Regulatory Commission's registration, as well as the risk of being unable to list on the BSE due to a failed public issuance.